The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important difference

Burden of Illness in Hereditary Angioedema: A Conceptual Model

(2015) A Bygum et al.   ACTA DERMATO-VENEREOLOGICA

Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema

(2015) Karsten Weller et al.   Current Opinion in Allergy and Clinical Immunology

Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients

(2015) J. R. Curtis et al.   ARTHRITIS CARE & RESEARCH

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

(2014) M. Cicardi et al.   ALLERGY

The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

(2014) T. Zuberbier et al.   ALLERGY

Interpreting Clinical Differences in BREAST-Q Scores

(2014) Stefan J. Cano et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Disease Activity Only Moderately Correlates with Quality of Life Impairment in Patients with Chronic Spontaneous Urticaria

(2013) I. Koti et al.   DERMATOLOGY

Development and construct validation of the angioedema quality of life questionnaire

(2012) K. Weller et al.   ALLERGY

Chronic Spontaneous Urticaria: How to Assess Quality of Life in Patients Receiving Treatment

(2011) Karsten Weller   ARCHIVES OF DERMATOLOGY